Category: Health & Medicines > Medicines > Griseofulvin
Country/Region: China State/Province: Guangdong
Main Products: Doxorubicin, Daunorubicin, Docetaxel, Vincristin
Business Type: Wholesaler, Buying House
Year Established: 2000
Employees: Above 1000 People
Plant Area: 30,000-50,000 square meters
Fax: 86-755-25878769
Main Markets: South America 8% Africa 11% Eastern Asia 10% Domestic Market 9% North America 12% Eastern Europe 9% Southern Europe 10% Mid East 8% Northern Europe 12% Oceania 11%
Trade Capacity: FOB, EXW, DAF
Contract Manufacturing: OEM Service Offered
Nearest Port: Shenzhen
Annual Revenue: Above US$100 Million
Total Revenue: Above US$100 Million
Export Revenue: confidential
Annual Output: US$10 Million - US$50 Million
Registered Capital: US$5 Million - US$10 Million
Export Percentage: 41% - 50%
Payment Modes: USD, EUR, GBP
Lead Time: 18 days
Import/Export Mode: LLC (Limited Liability Corp)